AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12932243
Drug: 5% minoxidil
RxNorm normalized name: MINOXIDIL 5 g in 100 mL TOPICAL LIQUID [ASDTOTIO 5% minoxidil]
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5% minoxidil topical solution
Trial: 8865946
Drug: Cefuroxime 1.5
RxNorm normalized name: cefuroxime 1.5 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 1.5 g as single shot prophylaxis before hemodilution (group A)
Trial: 8865946
Drug: Cefuroxime 1.5
RxNorm normalized name: cefuroxime 1.5 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 1.5 g as single shot prophylaxis after hemodilution (group B)
Trial: 1909700
Drug: Mesna (20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesna (20% of ifosfamide dose, intravenously, three times daily for 5 days)
Trial: 6090258
Drug: Adrenergic blockers
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenergic blockers (phentolamine and propranolol)
Trial: 6090258
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of opioid and adrenergic blockers
Trial: 30878146
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (clinical trial participants)
Trial: 8472520
Drug: ST‐679 (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ST‐679 (1200 mg, single oral dose)
Trial: 20817859
Drug: SDAP (10%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SDAP (10% spray-dried animal plasma)
Trial: 20817859
Drug: auSDAP (10%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: auSDAP (10% autoclaved spray-dried animal plasma)
Trial: 19387397
Drug: CM (5
RxNorm normalized name: fibrinogen/thrombin(human der) 9.5 cm X 4.8 cm (5.5 mg-2 unit/cm2) TOPICAL ADHESIVE PATCH, MEDICATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CM (5 g of creatine)
Trial: 19387397
Drug: PEG1.25 (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG1.25 (1.25 g of creatine)
Trial: 11474311
Drug: pantoprazole 20
RxNorm normalized name: pantoprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pantoprazole 20 mg daily
Trial: 11474311
Drug: ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranitidine 150 mg daily
Trial: 7920000
Drug: Methimazole treatment
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole treatment for 4 to 20 months (mean 10.6 months)
Trial: 3414572
Drug: [1‐13C]palmitic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [1‐13C]palmitic acid (9‐13.5 mg/kg body wt)
Trial: 3414572
Drug: [16‐13C]palmitic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [16‐13C]palmitic acid (9‐13.5 mg/kg body wt)
Trial: 21690318
Drug: Tobacco smoking
RxNorm normalized name: Tobacco leaf
DrugBank: Tobacco leaf (DB10710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobacco smoking with nicotine yield (0.05, 0.6, or 0.9 mg)
Trial: 10929922
Drug: Fexofenadine 60
RxNorm normalized name: fexofenadine 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine 60 mg twice daily
Trial: 18096307
Drug: Photodynamic diagnosis
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic diagnosis (PDD) with hexaminolevulinate (Hexvix) solution
Trial: 12873920
Drug: IV test
RxNorm normalized name: home HIV test kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV test dose (0.1 mL/kg) consisting of 1% lidocaine with 1:200,000 epinephrine (epinephrine 0.5 microg/kg)
Trial: 10723498
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily didanosine plus twice daily stavudine (group B)
Trial: 10723498
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily didanosine plus twice daily stavudine (group A)
Trial: 8528821
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not specified treatment)
Trial: 1958432
Drug: Gemfibrozil treatment
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemfibrozil treatment with good medication compliance (≥90% capsule consumption)
Trial: 1958432
Drug: Gemfibrozil treatment
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemfibrozil treatment with good medication compliance (≥90% positive gemfibrozil analyses)
Trial: 1958432
Drug: Gemfibrozil treatment
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemfibrozil treatment with good medication compliance (good compliance according to both digoxin marker measurements)
Trial: 1958432
Drug: Gemfibrozil treatment
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemfibrozil treatment with poor medication compliance (<50% capsule consumption)
Trial: 1958432
Drug: Gemfibrozil treatment
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemfibrozil treatment with poor medication compliance (<50% positive gemfibrozil analyses)
Trial: 1958432
Drug: Gemfibrozil treatment
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemfibrozil treatment with poor medication compliance (poor results in both digoxin marker measurements)
Trial: 6890361
Drug: Acebutolol 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol 300 mg
Trial: 3910303
Drug: Acebutolol 200
RxNorm normalized name: acebutolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol 200 mg
Trial: 6890361
Drug: Acebutolol (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (any dose)
Trial: 30921503
Drug: OLZ/SAM (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OLZ/SAM (10 mg OLZ/10 mg SAM) in fed conditions
Trial: 30921503
Drug: OLZ/SAM (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OLZ/SAM (10 mg OLZ/10 mg SAM) in fasted conditions
Trial: 23851908
Drug: Ribavirin (RBV)
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ribavirin (RBV) treatment
Trial: 15001247
Drug: Conventional radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional radiotherapy (with rectangular fields) to a dose of 66 Gy
Trial: 15001247
Drug: Three-dimensional conformal
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dimensional conformal radiotherapy to a dose of 66 Gy
Trial: 15001247
Drug: Dose levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose levels between 25 Gy and 60 Gy
Trial: 28714866
Drug: Both agents
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both agents
Trial: 25239483
Drug: Live attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live attenuated SA 14-14-2 JE vaccine manufactured in a new GMP facility
Trial: 12950711
Drug: Trazodone (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trazodone (mean dose = 105 +/- 57 mg at bedtime)
Trial: 10786962
Drug: Neutralizing antibody
RxNorm normalized name: Neutralizing antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutralizing antibody to tumor necrosis factor
Trial: 10786962
Drug: Recombinant interleukin
RxNorm normalized name: Recombinant interleukin 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant interleukin 1 receptor antagonist
Trial: 9561598
Drug: DTP-HB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP-HB vaccine administered at 2, 4, and 6 months
Trial: 9561598
Drug: DTP-HB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP-HB vaccine
Trial: 4036270
Drug: 0.1 ml
RxNorm normalized name: ethanol 0.1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 ml intradermally (ID)
Trial: 4036270
Drug: 0.1 ml
RxNorm normalized name: ethanol 0.1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 ml subcutaneously (SC)
Trial: 4036270
Drug: 1.0 ml
RxNorm normalized name: digoxin 0.25 mg in 1.0 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 ml SC
Trial: 28111208
Drug: Pre-operative intramuscular
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative intramuscular testosterone enanthate (2 mg/kg) administered in Group 2 (subdivided into Group 2A and Group 2B based on timing of surgery)
Trial: 25872501
Drug: Implementation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implementation of the management algorithm for tuberculosis diagnosis and treatment in intervention clinics.
Trial: 20031704
Drug: IVUS-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVUS-directed therapy
Trial: 2520847
Drug: Misoprostol 100
RxNorm normalized name: MISOPROSTOL 100MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol 100 mcg
Trial: 31401795
Drug: SNF472 (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SNF472 (intravenous formulation of myo-inositol hexaphosphate) administered 3 times per week for 12 weeks
Trial: 27893019
Drug: Blunt-needle injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blunt-needle injection (lidocaine, 2%; 27-gauge needle)
Trial: 27893019
Drug: Sharp-needle injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sharp-needle injection
Trial: 23822690
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (50 mg/kg body wt)
Trial: 9509896
Drug: Anti-platelet treatment
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-platelet treatment with dipyridamole
Trial: 8311489
Drug: CGS16949A 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS16949A 8 mg single dose
Trial: 8311489
Drug: CGS16949A 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS16949A 8 mg/day (multiple administration)
Trial: 8311489
Drug: CGS16949A 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS16949A 16 mg/day (multiple administration)
Trial: 8311489
Drug: CGS16949A (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS16949A (multiple administration)
Trial: 30001987
Drug: Pazopanib 400
RxNorm normalized name: PAZOPanib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pazopanib 400 mg/day
Trial: 26276968
Drug: Etanercept (ETN)
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept (ETN) 50 mg weekly for 12 weeks
Trial: 21968445
Drug: Quadrovax(®) vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrovax(®) vaccine
Trial: 21968445
Drug: TETRAct-Hib(®) vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TETRAct-Hib(®) vaccine
Trial: 19917097
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (techniques chosen by the surgeon)
Trial: 19917097
Drug: Standard non-surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard non-surgical treatment
Trial: 12615677
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg
Trial: 15492322
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg
Trial: 9526175
Drug: 5% glucose
RxNorm normalized name: Dextrose/Water 5% Oral Solution [ENFAMIL 5% GLUCOSE IN WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glucose solution containing 2g carnitine (Group B)
Trial: 9526175
Drug: 5% glucose‐enriched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glucose‐enriched solution (Group A)
Trial: 2202547
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg atenolol and 20 mg nifedipine (1 capsule once daily)
Trial: 2202547
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg atenolol and 20 mg nifedipine (2 capsules once daily)
Trial: 2202547
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg atenolol and 20 mg nifedipine (1 capsule or 2 capsules once daily)
Trial: 31532044
Drug: Moringa stem
RxNorm normalized name: stem bromelain
DrugBank: Stem bromelain (DB12249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moringa stem meal (MSM) at 100 g/kg
Trial: 31532044
Drug: Moringa stem
RxNorm normalized name: stem bromelain
DrugBank: Stem bromelain (DB12249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moringa stem meal (MSM) at 60 g/kg or less
Trial: 31532044
Drug: Moringa stem
RxNorm normalized name: stem bromelain
DrugBank: Stem bromelain (DB12249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moringa stem meal (MSM) at 0 g/kg (control)
Trial: 25408262
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of erlotinib 150 mg
Trial: 25408262
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of erlotinib 150 mg
Trial: 16691030
Drug: 1% pimecrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% pimecrolimus cream (Elidel) applied twice daily for 2 weeks
Trial: 7934970
Drug: Acipimox slow
RxNorm normalized name: acipimox
DrugBank: Acipimox (DB09055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox slow release (ACX‐SR, 500 mg)
Trial: 29084372
Drug: 1 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 μg of HGF per vocal fold
Trial: 29084372
Drug: 3 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 μg of HGF per vocal fold
Trial: 29084372
Drug: 10 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 μg of HGF per vocal fold
Trial: 23930950
Drug: Lactobacillus acidophilus
RxNorm normalized name: Lactobacillus acidophilus
DrugBank: Lactobacillus acidophilus (DB15823)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus acidophilus (10⁹ colony-forming units twice daily; n=20)
Trial: 14648521
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose and non‐nutritive sucking (NNS)
Trial: 10820932
Drug: Accelerated streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated streptokinase infusion over 15 minutes (group 1, n = 24)
Trial: 10820932
Drug: Conventional streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional streptokinase infusion over one hour (group 2, n = 23)
Trial: 8648213
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral doses of Ty800 (10^7, 10^8, 10^9, or 10^10 cfu)
Trial: 28077825
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of essential oil
Trial: 29499722
Drug: Antibiotics and
RxNorm normalized name: Antibiotics and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics and regular clinical assessment
Trial: 26806141
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment only (Control)
Trial: 7836217
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg)
Trial: 25075
Drug: Metoprolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (100 mg)
Trial: 1127891
Drug: Different treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different treatment conditions
Trial: 21613558
Drug: Serum 25-hydroxyvitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum 25-hydroxyvitamin D concentrations (≥52 nmol/L)
Trial: 19220313
Drug: Memantine 20-40
RxNorm normalized name: memantine hydrochloride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine 20-40 mg/day
Trial: 22434327
Drug: Good Behavior
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Good Behavior Game (GBG) intervention, with training and weekly on-site support from coaches.
Trial: 20362342
Drug: Sequential immunizations
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential immunizations (control group)
Trial: 15896512
Drug: Oligofructose (OF)
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oligofructose (OF) 6 g daily for 15 days
Trial: 10065691
Drug: Domperidone (a
RxNorm normalized name: Domperidone (as domperidone maleate) 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (a selective dopamine D2‐receptor antagonist)
Trial: 1959848
Drug: Sclerotherapy (paravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sclerotherapy (paravenous polidocanol [10 mg/ml] every 1 to 2 weeks until eradication)
Trial: 1959848
Drug: Propranolol (slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (slow-release preparation in one daily dose adjusted to provide about 25% heart rate reduction)
Trial: 25312529
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (ST) - conventional electrosurgical pencil
Trial: 19042026
Drug: Risperidone 0.5-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 0.5-4 mg/day
Trial: 15789141
Drug: Bovine colostrum
RxNorm normalized name: Bovine Colostrum
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine colostrum (COL; 20 g daily)
Trial: 8926739
Drug: Cannabinoid immunoassays
RxNorm normalized name: Cannabinol
DrugBank: Cannabinol (DB14737)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabinoid immunoassays with 50‐ng/mL cutoff
Trial: 8926739
Drug: Cannabinoid immunoassays
RxNorm normalized name: Cannabinol
DrugBank: Cannabinol (DB14737)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabinoid immunoassays with 20‐ng/mL cutoff
Trial: 8926739
Drug: Commercial cannabinoid
RxNorm normalized name: Cannabinol
DrugBank: Cannabinol (DB14737)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial cannabinoid immunoassay with a 50‐ng/mL cutoff
Trial: 19057518
Drug: Coadministered amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministered amlodipine 5 mg and atorvastatin 10 mg
Trial: 17324005
Drug: Cinacalcet 30
RxNorm normalized name: cinacalcet 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet 30 mg twice daily
Trial: 11870141
Drug: Combined data
RxNorm normalized name: NO DATA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined data from IvIg treatment
Trial: 11870141
Drug: Combined data
RxNorm normalized name: NO DATA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined data from placebo treatment
Trial: 7856293
Drug: 24-valent Klebsiella
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-valent Klebsiella capsular polysaccharide vaccine and eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously
Trial: 7856293
Drug: 24-valent Klebsiella
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-valent Klebsiella capsular polysaccharide vaccine and eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered 14 days apart
Trial: 24135593
Drug: 750 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 µg of AFB1/kg diet (750 ppb of AFB1)
Trial: 24135593
Drug: 75 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 µg of AFB1/kg diet (75 ppb of AFB1)
Trial: 21458097
Drug: Liraglutide (once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (once-daily injection for 16 weeks)
Trial: 21458097
Drug: T2DM (pre-treatment)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T2DM (pre-treatment)
Trial: 8281852
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg
Trial: 9665421
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (1200 mg/day)
Trial: 7655766
Drug: Pranidipine (1‐2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranidipine (1‐2 mg) once daily for 1‐2 weeks
Trial: 10210991
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) treatment
Trial: 1139128
Drug: Small doses
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small doses of subcutaneous sodium heparin
Trial: 27230862
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) + Usual Care (UC) for 16 weeks
Trial: 20376479
Drug: Compression treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compression treatment (n = 8) - wore full leg compression stockings for 12 h after exercise